KULA-18

N/A

Report date: 2025/01/26 18:44:58
NME

Base Information

Drug NameKULA-18
Drug Alias NameKULA-18
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPyruvate dehydrogenase kinase inhibitors
TargetsPyruvate dehydrogenase kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPartikula LLC
China Registration ClassN/A

Develop Information

Active CompaniesPartikula LLC
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A